New genetic screening aims to catch prostate cancer earlier in High-Risk men
NCT ID NCT07265414
Summary
This study is testing a more personalized screening method for men at high genetic risk of prostate cancer. Researchers want to see if using a specific blood test (PHI) and an advanced MRI scan can find aggressive cancers earlier than the current standard tests. The goal is to help men with a family history or specific gene mutations get diagnosed sooner when treatment may be more effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
IRCCS Humanitas Research Hospital
Milan, 20089, Italy
Conditions
Explore the condition pages connected to this study.